Roles of Metabotropic Glutamate Receptors in Brain Plasticity and Pathology
- 1 May 1995
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 757 (1) , 460-474
- https://doi.org/10.1111/j.1749-6632.1995.tb17506.x
Abstract
In summary, the mGluRs are a large family of receptor subtypes with diverse properties in terms of transduction coupling, pharmacology, and anatomical distribution. Many divergent studies have demonstrated that activation of these receptors can result in either neuroprotection or neuropathology. We hypothesized that the mGluRs of astrocytes may have a role in determining the response following administration of mGluR agonists in vivo, and we have defined a suitable in vitro model for the study of these receptors. The experimental plasticity demonstrated in the astrocyte culture model may represent a more general principle that conditions in the microenvironment may differentially alter mGluR subtype expression as part of development, functional specialization, or pathology. This astrocyte model of receptor regulation provides a system suitable for studying the effects of specific growth factors, neurotrophins, cytokines, and other substances released by neurons and glia that may act in both autocrine and paracrine fashions. Alteration in the ratios of receptors by such variables could then modify future signaling properties and neuroglial interactions, a form of conditioning of the astrocytic response that would alter the physiological output following glutamate release. One measure of the value of this model will be its usefulness in stimulating the generation of hypotheses that can be tested in vivo. For example, the morphology of the astrocytes when cultured in the defined medium has similarities to the morphology of astrocytes undergoing reactive gliosis in pathological states. It is also interesting to note that treatments that have been reported to increase excitatory amino acid-stimulated PI hydrolysis in ex vivo brain slices (lesions, ischemia, and kindling) are accompanied by reactive gliosis. Those findings combined with the present in vitro results lead us to speculate that mGluR5 expression may also be altered in vivo during reactive gliosis. If so, it will be important to examine the functional consequences of such a change with regard to the astrocytic response to injury and maintaining the balance between excitatory transmission and excitotoxicity.Keywords
This publication has 52 references indexed in Scilit:
- Pharmacological dissociation of glutamatergic metabotropic signal transduction pathways in cortical astrocytesEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- A Variant of Metabotropic Glutamate Receptor Subtype 5: An Evolutionally Conserved Insertion with No Termination CodonBiochemical and Biophysical Research Communications, 1993
- Immunohistochemical visualization of a metabotropic glutamate receptorNeuroReport, 1993
- Metabotropic glutamate receptors in brain function and pathologyTrends in Pharmacological Sciences, 1993
- In rats, the metabotropic glutamate receptor-triggered hippocampal neuronal damage is strain-dependentLife Sciences, 1993
- Cloning, Expression, and Gene Structure of a G Protein-Coupled Glutamate Receptor from Rat BrainScience, 1991
- Changes in excitatory amino acid modulation of phosphoinositide metabolism during developmentDevelopmental Brain Research, 1990
- Stimulation of Inositol Phospholipid Hydrolysis by Excitatory Amino Acids Is Enhanced in Brain Slices from Vulnerable Regions after Transient Global IschemiaJournal of Neurochemistry, 1989
- Activation of polyphosphoinositide metabolism as a signal‐transducing system coupled to excitatory amino acid receptors in astroglial cellsGlia, 1989
- Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.The Journal of cell biology, 1980